ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1014

Factors Associated with Fibromyalgia Diagnosis amongst People Meeting Criteria: Results from UK Biobank

Sung-A Kim, Gary Macfarlane and Marcus Beasley, University of Aberdeen, Aberdeen, United Kingdom

Meeting: ACR Convergence 2025

Keywords: Diagnostic criteria, fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1007–1037) Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: The diagnosis of fibromyalgia (FM) is challenging due to its reliance on patient-reported symptoms, the absence of definitive biomarkers, and numerous overlapping comorbidities. Discrepancies between diagnostic criteria and clinical practice imply the possibility of diagnostic biases, complicating timely and accurate identification. This study aimed to identify factors associated with receiving a FM diagnosis, among individuals who met 2016 criteria, and explore potential barriers to diagnosis.

Methods: Using data from UK Biobank, a total of 27 potential factors across four biopsychosocial domains were analysed for differences between diagnosed and undiagnosed individuals. Multivariate log-binomial regression was used within and across domains to evaluate prevalence ratios (PR) regarding the independent association of factors with receiving a FM diagnosis. To avoid potential selection bias, we conducted a sensitivity analysis including all UK Biobank participants who completed the Experience of Pain question, regardless of whether they met the 2016 FM criteria.

Results: Among the 4,197 individuals meeting FM criteria, 72.6% reported not having received a diagnosis. We identified eight factors significantly associated with not being diagnosed: being male (fully adjusted PR 0.47, 95% confidence interval 0.41-0.56), older age (0.85, 0.75-0.96), self-reported concomitant diagnosis of neuropathy (0.91, 0.83-0.99), shorter pain duration (0.56, 0.41-0.76), lower polysymptomatic distress scores (0.56, 0.51-0.62), and less frequent fatigue (0.85, 0.76-0.96). In contrast diagnosis was more likely amongst people who also reported a diagnosis of chronic fatigue syndromes (1.65, 1.50-1.82) and complex regional pain syndrome (1.13, 1.03-1.25). The sensitivity analysis conducted on the whole population sample demonstrated results generally consistent with the main analysis.

Conclusion: Our research has identified significant disparities in the diagnosis of FM at the population-level in the UK, particularly among patients without stereotypical characteristics, with less severe symptoms, or the existence of concomitant chronic pain conditions. Understanding these diagnostic patterns can help improve alignment between criteria for identifying FM and real-world practice.

Supporting image 1Figure 1. Diagnosis status among people meeting the 2016 fibromyalgia criteria

Supporting image 2Figure 2. Factors associated with fibromyalgia diagnosis in the fully adjusted model 3


Disclosures: S. Kim: None; G. Macfarlane: None; M. Beasley: None.

To cite this abstract in AMA style:

Kim S, Macfarlane G, Beasley M. Factors Associated with Fibromyalgia Diagnosis amongst People Meeting Criteria: Results from UK Biobank [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/factors-associated-with-fibromyalgia-diagnosis-amongst-people-meeting-criteria-results-from-uk-biobank/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-associated-with-fibromyalgia-diagnosis-amongst-people-meeting-criteria-results-from-uk-biobank/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology